Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released May 6, 2014, after the close
10-Q filed May 6, 2014, 36 days after period end · 0001193125-14-184864
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Revenue | $30.00K | $417.00K | $450.00K | $435.00K |
| Net Income | -$17.83M | -$6.12M | -$6.22M | -$5.83M |
| EPS Diluted | -$0.19 |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.08 |
| -$0.12 |
| -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
